[Erythropoietin, renin, aldosterone, and blood volume in primary and secondary polycythemia].
D000328:Adult; D000368:Aged; D000450:Aldosterone / Q000032:analysis* / Q000652:urine; D000804:Angiotensin II / Q000096:biosynthesis; D001794:Blood Pressure; D001810:Blood Volume; D001811:Blood Volume Determination; D004232:Diuretics / Q000008:administration & dosage; D004921:Erythropoietin / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000096:biosynthesis; D005260:Female; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D000860:Hypoxia / Q000097:blood; D008113:Liver Neoplasms / Q000097:blood; D008297:Male; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists; D010949:Plasma / Q000378:metabolism; D011086:Polycythemia / Q000378:metabolism; D011187:Posture; D012083:Renin / Q000032:analysis* / Q000096:biosynthesis / Q000378:metabolism; D000092502:Renin Inhibitors
D000450:Aldosterone; D000804:Angiotensin II; D004232:Diuretics; D004921:Erythropoietin; D006454:Hemoglobins; D000451:Mineralocorticoid Receptor Antagonists; D012083:Renin; D000092502:Renin Inhibitors
Erythropoetin, Renin, Aldosteron und Blutvolumina bei primärer und sekundärer Polycythämie.